Literature DB >> 2017642

Selection and training of patients for outpatient intravenous antibiotic therapy.

R B Brown1.   

Abstract

Outpatient intravenous antibiotic therapy (OPIVAT) requires selection of patients who are medically and psychologically stable, are capable of being trained to administer iv medications, will not abuse the iv system, and have insurance coverage. Patients with conditions such as osteomyelitis, septic arthritis, pelvic inflammatory disease, endocarditis, and skin and soft tissue infections are appropriate candidates. As clinical experience grows, patients with increasingly complex conditions are being successfully treated at home. Before OPIVAT can be utilized, mode of iv access, length of therapy, antibiotic selection, laboratory tests, and physician of record must be determined. Patients must be instructed how to handle emergencies. With appropriate training, such patients learn to properly manage drugs and equipment and to recognize complications. Patients who cannot be treated at home may be candidates for OPIVAT under direct medical supervision. Technical advances in pumps and catheters--as well as future changes in Medicare reimbursement--may greatly increase the number of patients who are capable of receiving OPIVAT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2017642     DOI: 10.1093/clinids/13.supplement_2.s147

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  5 in total

1.  Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks?

Authors:  D N Williams
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

2.  Efficacy of teicoplanin and autoradiographic diffusion pattern of [14C]teicoplanin in experimental Staphylococcus aureus infection of joint prostheses.

Authors:  A Saleh Mghir; A C Crémieux; R Bleton; F Ismael; M Manteau; S Dautrey; L Massias; L Garry; N Sales; B Mazière; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 3.  Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA.

Authors:  A D Tice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

4.  Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis.

Authors:  W Graninger; C Wenisch; E Wiesinger; M Menschik; J Karimi; E Presterl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-07       Impact factor: 3.267

5.  Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.

Authors:  Kavita P Bhavan; L Steven Brown; Robert W Haley
Journal:  PLoS Med       Date:  2015-12-15       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.